Cargando…
Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients
Several previous studies reported that the neutrophil-to-lymphocyte ratio (NLR) could be a promising prognostic factor for patients with cancer. We aimed to determine the prognostic value of NLR in patients with advanced pancreatic cancer (APC) following palliative chemotherapy. We retrospectively r...
Autores principales: | Xue, Peng, Kanai, Masashi, Mori, Yukiko, Nishimura, Takafumi, Uza, Norimitsu, Kodama, Yuzo, Kawaguchi, Yoshiya, Takaori, Kyoichi, Matsumoto, Shigemi, Uemoto, Shinji, Chiba, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987090/ https://www.ncbi.nlm.nih.gov/pubmed/24519894 http://dx.doi.org/10.1002/cam4.204 |
Ejemplares similares
-
Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer
por: Kondo, Tomohiro, et al.
Publicado: (2018) -
Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity‐modulated radiotherapy for resectable pancreatic cancer: A prospective, open‐label, phase II study
por: Masui, Toshihiko, et al.
Publicado: (2023) -
Autoimmune Pancreatitis Exhibiting Multiple Mass Lesions
por: Shiokawa, Masahiro, et al.
Publicado: (2011) -
Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution
por: Masui, Toshihiko, et al.
Publicado: (2022) -
A case of successful conversion from everolimus to surgical resection of a giant pancreatic neuroendocrine tumor
por: Sato, Asahi, et al.
Publicado: (2017)